Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false. The description goes well beyond that: it explains graceful degradation (EDGAR identifiers still return if GLEIF/OpenFIGI is down), cascading internal lookups, ambiguous-match behavior (returns `figi_candidates` and asserts nothing), and explicit `unresolved` listing for missing identifiers. These are non-obvious behaviors an agent must know, and they are not present in annotations. No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but it is front-loaded with examples and structured into a clear flow: usage phrasings, 'Use FIRST', supported types with detailed behaviors, and graceful-degradation notes. Every sentence adds operational value for a complex tool. It is not tautological or wasteful, though it could be tightened slightly without losing meaning. A 4 reflects that it's appropriately sized for the complexity but not minimal.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple identifier sources, edge cases like non-equity instruments and ambiguous names), the description is remarkably complete. It covers what happens on unmatched names, multiple matches, unavailable external sources, and the exact format for bond issuers. Nothing an agent needs to call this tool correctly is missing, and it even provides background on why certain behavior is correct.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% (both parameters described), so the baseline is 3. But the description adds substantial meaning: for `value`, it clarifies that a bond's value should be the issuer exactly as printed, not the full noun phrase, and that an ISIN resolves to the legal entity. For `type`, it explains the exact identifier sets each type returns. This goes far beyond the schema's simple enum, guiding correct input formatting.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user phrasings ('What's the ticker for…', 'find the CIK for…') and states the core purpose: resolving a name to canonical identifiers other tools require. It names the specific identifier types per entity type (CIK, ticker, LEI, FIGI for company; RxCUI for drug) and explicitly says 'Use FIRST whenever you have a name but need an ID', which clearly differentiates it from siblings like entity_profile or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives a crisp rule: 'Use FIRST whenever you have a name but need an ID.' It also explains when to choose company vs. drug and warns against passing full noun phrases for bonds. It doesn't name specific alternative tools, but the 'use FIRST' instruction is strong enough to route an agent, and it notes that the tool replaces 2-3 manual lookups, clarifying its role in the workflow.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several clusters blur together: ask_pipeworx, ask_pipeworx_beta (explicitly identical today), and ask_pipeworx_grounded share routing, while discover_tools/suggest_questions and the Polymarket edge/arbitrage/fill-risk tools have overlapping discovery purposes. Rich descriptions reduce some confusion, but an agent must read carefully to avoid misselection.

Naming Consistency3/5

Most names are lowercase snake_case, but there is no consistent verb_noun pattern: ask_pipeworx/beta/grounded and polymarket_* are domain-prefixed, entity_profile/recent_changes are noun phrases, and query/metadata/remember are bare verbs or nouns. The naming is still readable and subfamilies share prefixes, so it is mixed rather than chaotic.

Tool Count2/5

34 tools is above the comfortable range for a single MCP server, and several could be folded together (the beta variant, visibility checks, and Polymarket scanners). The breadth reflects a large platform, but the surface feels heavy for an agent to select from confidently.

Completeness4/5

The query side is strong: PA Open Data has datasets/metadata/query coverage, and Pipeworx provides ask, deep_research, entity_profile, compare, recent_changes, validate_claim, plus subscriptions and memory with lifecycle coverage. Minor gaps: descriptions promise resolvable pipeworx:// citations but no resource/read tool is exposed, and there is no direct way to fetch an arbitrary record by citation.